Skip to main content

Table 3 Preoperative clinical characteristics in patients with and without T2DM remission (Including complete and partial remission) at 12 months after surgery

From: Effect of Roux-en-Y gastric bypass on patients with type 2 diabetes mellitus and body mass index of 27.5–35 kg/m2–a single center retrospective cohort study

Variable

No Remission (N = 18)

Remission (N = 16)

P

Age(year)

44.5 ± 7.22

39.50 ± 6.89

0.047

Male (female)

8(10)

7(9)

0.968

Duration of diabetes (year)

6.83 ± 1.58

4.94 ± 1.39

0.001

Smoking (%)

10(55.6%)

8(50%)

0.746

BMI (kg/m2)

29.95 ± 1.07

31.97 ± 1.76

0.000

HDL (mmol/l)

1.05 ± 0.29

0.96 ± 0.29

0.404

LDL (mmol/l)

2.22 ± 0.85

2.53 ± 1.21

0.393

TC (mmol/l)

4.70 ± 1.14

5.11 ± 1.03

0.279

TG (mmol/l)

3.21 ± 2.79

4.99 ± 3.63

0.244

HbA1c (%)

8.35 ± 1.75

8.98 ± 2.04

0.338

FPG (mmol/l)

8.95 ± 3.39

10.77 ± 4.54

0.192

FINS(µU/ml)

23.40 ± 16.01

35.88 ± 9.41

0.010

FCP (ng/ml)

2.18 ± 0.72

3.43 ± 1.41

0.002

Peripheral glucose disposal rate (mg/kg/min)

3.65 ± 1.02

2.76 ± 0.71

0.006

  1. BMI, body mass index; LDL, low density lipoprotein cholesterol; HDL, high-density lipoprotein cholesterol; TC, total cholesterol; TG, triglycerides; FPG, fasting plasma glucose; FCP, fasting C-peptide; FINS, fasting insulin